Roberts David B 4
4 · LEMAITRE VASCULAR INC · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
LEMAITRE VASCULAR (LMAT) President David B. Roberts Sells Shares
What Happened
- David B. Roberts, President and Director of Lemaitre Vascular (LMAT), executed an open‑market sale of 8,464 common shares on Feb 27, 2026 for a total of about $903,958 (weighted average $106.80). Separately, on Feb 26, 2026 he received shares from the settlement/vesting of Performance Share Units (PSUs) and dividend equivalent rights (acquisitions at $0.00). A small number of shares were withheld to cover tax obligations related to the PSU vesting.
Key Details
- Primary sale: 8,464 shares sold on 2026-02-27; weighted average price $106.80; total ≈ $903,958. (Execution price range $105.85–$107.30.)
- Awards/settlements on 2026-02-26: acquisitions reported — 1,514 shares (PSU from 12/6/2024), 146 shares (PSU from 2/18/2025), and release of dividend equivalent rights (one-for-one share equivalents).
- Option/derivative activity: small exercise/conversion entries of 3 shares (M code) at $0.00.
- Tax withholding: 134 shares and 13 shares were withheld/treated as disposed to satisfy tax withholding on PSU vesting (F codes) for totals of $15,234 and $1,478 respectively; these withholding transactions are exempt under Rule 16b‑3(e).
- Filing: Form 4 filed 2026-03-02 for transactions dated 2026-02-26 and 2026-02-27. Filing appears to be timely under the two business‑day rule.
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
Context
- Most shares received were from PSU vesting (awards), not open‑market purchases — the large activity here is a sale of vested/settled shares. Tax‑withholding share disposals are routine and exempt. The sale does not by itself indicate a change in company outlook; it reflects a combination of award settlement and an open‑market sale.
Insider Transaction Report
Form 4
Roberts David B
DirectorPresident and Director
Transactions
- Award
Common Stock
[F1]2026-02-26+1,514→ 26,444 total - Award
Common Stock
[F2]2026-02-26+146→ 26,590 total - Exercise/Conversion
Common Stock
[F3]2026-02-26+3→ 26,593 total - Tax Payment
Common Stock
[F4]2026-02-26$113.69/sh−134$15,234→ 26,456 total - Tax Payment
Common Stock
[F5]2026-02-26$113.69/sh−13$1,478→ 26,443 total - Sale
Common Stock
[F6]2026-02-27$106.80/sh−8,464$903,958→ 17,979 total - Exercise/Conversion
Dividend Equivalent Rights
[F7]2026-02-26−3→ 9.38 total→ Common Stock (3 underlying)
Footnotes (7)
- [F1]These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years.
- [F2]These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on February 18, 2025. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on December 6th over the next three years (2026, 2027 and 2028).
- [F3]Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- [F4]These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- [F5]These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on February 18, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- [F6]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.85 to $107.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- [F7]These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-03-02